- Home
- VTEX vs OPK Comparison
VTEX vs OPK Comparison
Compare VTEX & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTEX
- OPK
- Stock Information
- Founded
- VTEX 1999
- OPK 2007
- Country
- VTEX Cayman Islands
- OPK United States
- Employees
- VTEX N/A
- OPK N/A
- Industry
- VTEX Computer Software: Prepackaged Software
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- VTEX Technology
- OPK Health Care
- Exchange
- VTEX Nasdaq
- OPK Nasdaq
- Market Cap
- VTEX 1.1B
- OPK 1.0B
- IPO Year
- VTEX 2021
- OPK 1995
- Fundamental
- Price
- VTEX $4.12
- OPK $1.41
- Analyst Decision
- VTEX Buy
- OPK Buy
- Analyst Count
- VTEX 4
- OPK 4
- Target Price
- VTEX $7.83
- OPK $2.75
- AVG Volume (30 Days)
- VTEX 1.5M
- OPK 1.9M
- Earning Date
- VTEX 11-04-2025
- OPK 11-06-2025
- Dividend Yield
- VTEX N/A
- OPK N/A
- EPS Growth
- VTEX 48.79
- OPK N/A
- EPS
- VTEX 0.05
- OPK N/A
- Revenue
- VTEX $230,497,000.00
- OPK $664,029,000.00
- Revenue This Year
- VTEX $11.14
- OPK N/A
- Revenue Next Year
- VTEX $15.19
- OPK $0.84
- P/E Ratio
- VTEX $79.02
- OPK N/A
- Revenue Growth
- VTEX 4.53
- OPK N/A
- 52 Week Low
- VTEX $3.92
- OPK $1.11
- 52 Week High
- VTEX $7.58
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- VTEX 35.03
- OPK 54.41
- Support Level
- VTEX $3.97
- OPK $1.34
- Resistance Level
- VTEX $4.14
- OPK $1.44
- Average True Range (ATR)
- VTEX 0.12
- OPK 0.04
- MACD
- VTEX 0.08
- OPK 0.00
- Stochastic Oscillator
- VTEX 59.65
- OPK 65.00
About VTEX VTEX
Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.